Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Why Are HIV Rates So High in Russia?

Russia is home to one of the fastest-growing HIV and AIDS epidemics in the world, abetted by policies that promote infections rather than curbing them.

Published
3 hours ago
From
International Business Times
What to Do When a Patient Admits an H.I.V. Phobia

She had been volunteering at a drop-in center for the homeless, helping to prepare dinner, when she felt a sting in the tip of the finger and looked down to see a red mark and a dot of blood. She could not find the object that had poked her, but she knew immediately what might have happened: She had seen a few used syringes lying around the place, and perhaps one had somehow gotten into the sink and perhaps she had stuck her finger with it, and perhaps it had just been used by an H.I.V.-infected addict, and perhaps right that minute, the virus was coursing through her own veins. So of course she went to the nearest emergency room. She knew that medication taken promptly could prevent H.I.V., and she wasn’t taking any chances.

Published
10 hours ago
From
New York Times
Drug use strongly associated with sex, condomless sex and STIs in gay men living with HIV in England

A large survey of gay and bisexual men living with HIV and attending eight sexual health clinics in England has found that half of them had used

Published
10 hours ago
By
Gus Cairns
HIV-fighting intravaginal ring research nets $20M from NIH

The U.S. National Institutes of Health devoted $20 million to a group of institutions including Miriam Hospital in Rhode Island to develop an HIV drug-delivering intravaginal ring. The design of a successful ring is a priority in HIV research, and the sustained release of drugs the ring offers could eventually play a crucial role in HIV prevention in the developing world.

Published
15 September 2014
From
Fierce Drug Delivery
The Enfant Terrible of AIDS Activism Reaches a New Low

Michael Weinstein, president of the AIDS Healthcare Foundation, is many things—professional provocateur; contrarian pariah; enfant terrible of the AIDS activism world. But here’s one thing he is not: a reliable source on any matters relating to HIV/AIDS.

Published
15 September 2014
From
Slate
Learning about additional HIV prevention methods doesn’t undermine gay men’s intentions to use condoms

Health promotion interventions can combine information about condoms and alternative biomedical prevention methods without undermining attitudes and intentions to use condoms, according to an experimental study published in

Published
15 September 2014
By
Roger Pebody
Change to recommended regimen for post-exposure prophylaxis (PEP)

The Expert Advisory Group on AIDS (EAGA) has recommended a change in the recommended regimen for post-exposure prophylaxis from tenofovir/emtricitabine with Kaletra to tenofovir/emtricitabine with raltegravir.

Published
11 September 2014
From
Expert Advisory Group on AIDS (EAGA)
Researcher has a radical idea for a drinkable, probiotic HIV vaccine

Like others before him, Jean-Marie Andrieu believes he may have hit upon the long sought after HIV vaccine. And like numerous other treatments under development, the hitch is that the vaccine has only thus far only shown to be effective in protecting monkeys against the Simian Immunodeficiency Virus or SIV, the monkey equivalent to HIV.

Published
11 September 2014
From
Washington Post (blog)
World Leaders Call For Ending Criminalization of Drug Use and Possession and Responsible Legal Regulation of Psychoactive Substances

Former Presidents of Brazil, Chile, Colombia, Mexico, Poland, Portugal and Switzerland Join With Kofi Annan, Richard Branson, George Shultz, Paul Volcker And Others To Make Bold, New Recommendations for Major Paradigm Shift in Global Drug Policy on the Road to UN Special Session on Drugs in 2016.

Published
10 September 2014
From
Global Commission on Drug Policy
Drug-level study shows feasibility of long-acting integrase inhibitor cabotegravir

A pharmacokinetic (PK) analysis presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy this week in Washington, DC, confirmed that the long-acting HIV integrase inhibitor cabotegravir (formerly GSK1265744) reaches adequate target levels in the blood, setting the stage for efficacy trials for HIV treatment and pre-exposure prophylaxis (PrEP).

Published
10 September 2014
From
HIVand hepatitis.com
← First12345...362Next →

Filter by country